Healthcare -
Biotechnology - NASDAQ - US
$ 4.02
-0.248 %
$ 240 M
Market Cap
5.51
P/E
ELDN - COST OF REVENUE
Cost of Revenue ELDN - Eledon Pharmaceuticals, Inc.
374 K
LAST VALUE
38.49%
2 YEAR CAGR
102.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR